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Abstract In this paper we present MANTRA (Mobile ANticoagulant TheR-
Apy), a project aimed at studying feasibility and acceptability of the introduc-
tion of mobile technology in the management of anticoagulant therapy involv-
ing both patients and health practitioners in their design. By the evaluation
of the MANTRA Project, we developed a general approach to mHealth in
the remote management of chronic diseases by supporting the communication
among patients and healthcare practitioners. Patients usually have to make
frequent visits to surgeries to meet nurses for the tests, and General Practition-
ers (GPs) for receiving drug prescriptions. We report on the implementation of
the project as a proof of concept in London. A group of patients, General Prac-
titioners, nurses, and healthcare assistants from the National Health Service
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(NHS) participated in design and evaluation phases. The distinct characteris-
tics of the NHS as one of the world’s largest publicly funded health services
posed a number of sociotechnical challenges to the design team. We present
how we approached and addressed these challenges through MANTRA. Pa-
tients and Healthcare practitioners recognized the validity of our proposed
design approach not only for supporting the remote therapy practice preserv-
ing an efficient and effective communication with the patients, but also as a
way for better managing resources in anticoagulant clinics in the context of
the NHS. With our research we explored the process that needs to be followed
to develop a mobile system that would fit the sociotechnical ecosystem of anti-
coagulant therapy. Furthermore, we are now able to identify the changes that
will be necessary in the ecosystem itself to make an effective use of the mobile
system.
Keywords Anticoagulant Therapy · Chronic Diseases · mHealth · Mobile
Devices · Sociotechnical Design · Telemedicinee
1 Introduction
In this paper we present a general approach to mHealth in the remote man-
agement of chronic diseases by supporting the communication among patients
and healthcare practitioners. Since the blood coagulation tests are usually
performed in surgeries, patients have to make frequent visits to meet nurses
for the tests and General Practitioners (GPs) for receiving drug prescriptions.
This approach was developed as a core goal of a Leverhulme Trust funded re-
search project, MANTRA (Mobile ANticoagulant TheRApy). The main goal
of the MANTRA Project was to study feasibility and acceptability of the in-
troduction of mobile technology in the management of anticoagulant therapy
involving both patients and health practitioners in their design [3,2].
In this paper, we report on the implementation of the project as a proof of
concept in a London community health centre, also referred to as a surgery in
Britain. A group of patients, General Practitioners (medical doctors), nurses,
and healthcare assistants from the National Health Service (NHS) partici-
pated in the design and evaluation of this device. The distinct characteristics
of the NHS as one of the world’s largest publicly funded health service posed
a number of sociotechnical challenges to the design team. We classified the
challenges into four main classes: quality of life, prescription management,
treatment schedule, and nutrition. In the paper, we present in detail how we
approached and addressed these challenges for our proposed mHealth solu-
tion. The results proved a real interest both from the patients and from the
surgery’s team members. The latter, in particular, recognize the validity of the
proposed design approach not only for supporting the remote therapy practice
preserving an efficient and effective communication and sharing of records with
the patients, but also as a way for better managing resources in anticoagulant
clinics.
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2 Oral Anticoagulation Therapy
Oral anticoagulant therapy is aimed at preventing the formation of thrombus.
People at risk of developing thrombosis have to take anticoagulant treatment
once a day in a dosage that varies depending on the results of an INR (In-
ternational Normalised Ratio) test (see Figure 1) [36]. The two main reasons
for coagulation therapy are venous thromboembolism and atrial fibrillation.
Venous thromboembolism (VTE) [36] [4] is the presence of coagulated blood,
a thrombus, in a major blood vessel. VTE has the potential to cause signifi-
cant harm by blocking blood flow to major organs and tissues. Many are the
possible causes for coagulation diseases – e.g. major general surgery, multiple
trauma, hip fracture. Besides, there are also some risk factors, like increasing
age, cardiac or respiratory failure, prolonged immobility, presence of central
venous lines, estrogens, and a wide variety of inherited and acquired haema-
tological conditions [10]. Most of the times a combination of causes and risk
factors are present together in a patient. Atrial Fibrillation (AF) [10] is a
cardiovascular disease that is associated with an increased risk of thrombus
formation and risk of stroke in patients that are affected by it.
The management of both VTE and AF requires treatment with Warfarin,
an oral anticoagulation drug, in a dosage that needs to be adjusted on the
basis of the INR test results. The INR test measures how long it takes for
the blood to clot, i.e. the prothrombin time. The dose of anticoagulant is
adjusted (increased or decreased) in order to maintain the INR result within
an appropriate range. The INR is tested every 2-3 days on the commencement
of treatment but once the levels have stabilized the interval between tests will
change to between 7 and 20 days. INR tests are usually performed in clinics or
laboratories therefore patients have to make frequent visits to have blood taken
and for the healthcare practitioner to make the decision about the appropriate
anticoagulant dose. The patient must then take exactly the dose prescribed by
the healthcare practitioner. This can be difficult for elderly or disabled people
and disruptive to their daily lives.
Given the high diversity of situations that may lead to anticoagulant ther-
apy, a very wide spectrum of the population might be affected by this: Chil-
dren, teenagers, adults and elderly. Each of these groups of people would
present different difficulties and needs and their daily life may be influenced
in different ways.
One of the most diffused problems for anticoagulant patients in their elderly
is that they may miss the daily dose, or they may take the correct dose twice a
day. Monitoring this kind of events means to take constant care of the patient
night and day and this can be made only if enough time/money resources
are present and/or if family members are available to take care or her/him.
The assumption of anticoagulant drugs is complex because of the frequently
variation of their dosage. In particular, in the UK this task is made even
harder because of the combination of some information at the same time: the
patient has to remember the dosage to be assumed in a specific day; S/he
has to choose from 4 kinds of pills which one is the correct one following a
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colour-code but the prescription is expressed in number of mg. as indicated
on each pill. These issues may lead to mistakes not only in elderly community,
but also for the others. Taking care of a child affected by coagulation diseases
is a very time-consuming activity that is very hard to manage for working
parents. Concerning teenage patients, giving them the whole responsibility of
the management of their cure could be very stressful, and they may not be
always very reliable.
Another serious problem related to coagulation diseases cure is given by
the fact that INR tests are mostly performed in clinics and laboratories and
this means that with a certain frequency the patient has to move to have the
test made. Moreover, even if the result of the test is immediately given, the
new dosage of the drugs is decided by a healthcare practitioner who has to
communicate it to the patient face to face, by email or via fax. If the patient
is not provided with email or fax devices, s/he has to stay in the facility until
the healthcare practitioner is ready to communicate the new dosage.
Last but not the least important influence on the normal life of a person
is nutrition. As reported in [12], foods rich in vitamin K may affect the INR
result. Such foods include green leafy vegetables, chick peas, liver, egg yolks,
cereals containing wheat bran and oats, mature cheese, blue cheese, avocado
and olive oil. For anticoagulant patients is always needed to have access to the
list of food they may assume/avoid and this could be a very big problem for
children, teenagers and elderly and implicates in general the need of a very
strong motivation to take care of themselves.
Our research is based in the United Kingdom, therefore we studied how an-
ticoagulant therapy is put in practice by the NHS system. In the UK, the mon-
itoring of oral anticoagulation therapy is performed in hospital anticoagulation
clinics. In a document distributed by [30], the setting up of anticoagulation
clinics in primary care is described in terms of issues, quality control, audit,
and costs. The report estimates that on the general population of patients
with AF, the prevalence for patients on oral anticoagulation therapy is about
1-1.5%. As relevant costs for a clinic, £100 to £1000 have to be considered
for a Computerized Decision Support Software (CDSS), a system that helps
the clinic staff to maintain the quality of anticoagulation control but at the
same time allows to reliably increase the average period between INR tests.
As ongoing costs, the report lists the main costs per test, that are related to
reagents, nursing staff time per hour, administration staff time, accommoda-
tion expenses (e.g., heating, light, and cleaning) and all others administrative
costs related to the clinic management and its relationship with NHS accred-
itation.
Obviously, reducing the need for patients to visit personally the clinics,
sometimes even may times per month, will reduce the costs of the clinics. On
the other hand, a first initial investment has to be taken into account but as
discussed in literature (e.g. [23]), such investment would lead in future costs
reduction and advantages for the entire health system and patients’ quality of
life.
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3 Literature Review
3.1 Personal Health Records and mHealth
Our research is focused on providing to patients and health practitioners sys-
tems able at supporting remote, mobile, and asynchronous communication for
an effective, safe, and reliable chronic diseases monitoring. Therefore, two are
the main fields that we address: personal health records and mHealth (as a spe-
cific form of telemedicine based on the use of mobile devices and technology).
We observe these two fields from a double perspective, the one of healthcare
practitioners and the one of the people affected by chronic diseases.
The scientific literature available today strongly proves how the use of elec-
tronic management of health records can be of advantage both for patients and
for healthcare practitioners, especially with what concerns a better manage-
ment of National Health Systems.
A panel at CHI 2013 [8] invited scholars in this field to discuss the impact
that technology plays on the relationship and interaction between patients and
healthcare practitioners. In particular, the organizers identified three main key
points that are worth to be considered: first, the effect that the presence of
computers in the exam-rooms or patients rooms have on the conversation
between patient and GP. This peculiar aspect of the synchronous co-located
interaction between the two actors may often lead to a loss of empathy in
the way the GP addresses the patient’s needs. Secondly, the problems that
affect asynchronous remote interaction, that are mainly related to the risk of
patients and providers being afraid of learning new ways of communicating
with each other and help them to understand the potentials of this specific
setting. Lastly, the changes in the traditional roles of patients and healthcare
providers with the introduction of more and more pervasive and ubiquitous
technologies. The proactivity of patients in sending their own test results to
the GPs may lead to great advantages in a long term perspective, but it is
undoubtedly hard to be understood and acknowledged in the short term.
A study focused on understanding the shift that eHealth may cause on the
relationship between patient and healthcare provider is published in [11] where
the authors report their findings by identifying 5 potential changes (sometimes
overlapping): 1) Internet health Websites may become a replacement for face-
to-face consultations influencing deeply the patients understanding of their
health conditions and putting at risk their own safety and future. However,
the same study points out how in literature it is proved that the patients do
not usually loose the interest in meeting their GP for examination and con-
sultation; 2) Supplement existing relationships and forms of care, that means
making the computer-mediated conversation between patient and GP an ac-
tual bi-directional transaction but always allowing the receiver (the GP) driv-
ing the communication; 3) Create favorable circumstances for improvements
or for strengthening patient participation, by mitigating mechanism, offering
a training ground, and implementing a so-called lever effect; 4) Managing the
issues that the healthcare practitioners might encounter, like the feeling of
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power loss, the fear of damaging the relationship with the patients during a
remote conversation, and to loose control over the sources of information that
tend to proliferate very fast due to technological advances; 5) Forcing the pa-
tient to become a more capable conversation partner because s/he needs to
provide the doctor with information that the doctor cannot obtain through
remote conversation.
mHealth is aimed at providing remote health care by the use of mobile tech-
nology and devices. In [19] a systematic review on scientific literature about
the management of chronic diseases has been presented and discussed. In par-
ticular, the review included the analysis of 107 papers and compared usability,
feasibility, and acceptability of mobile tools and platform used. From the re-
sults, it emerged that the most commonly used mobile technology (40.2%), was
still Short Message Service (SMS). Particularly, about the practice of mHealth
for anticoagulant therapy management (that is the specific application domain
we consider in our research), several studies have been carried out in the past
years but none of them ended in actual implementation into practice. In a
pilot study in 2006 [17], home telematic devices have been tested with 19 an-
ticoagulant patients over 5 months. The device was used to transmit the INR
result to a remote server. The prescription was then given by telephone to
the patient, because the device was only able to receive from the server the
date of the next test. Due to many severe technical and software problems
and failures only 9 home telematic devices were tested. The study proved the
feasibility of telemedicine for anticoagulant therapy but with many technical
constraints. First of all, this study promoted the use of home devices that
are not mobile but need to be connected to landlines and therefore cannot be
used while travelling. Another problem was the lack of bidirectional commu-
nication via the home telematic device: the healthcare practitioners needed to
call the patients of the phone to communicate them the next Warfarin prescrip-
tion and this procedure was obviously highly error prone. In 2008, Salvador
et al. [35] proposed the use of telemedicine for first monitoring and then es-
tablishing self-management of anticoagulant therapy. The study involved 54
patients over more than two years and led to conclusions related to the fea-
sibility of telemedicine in anticoagulant therapy and of the introduction of
self-management approach, i.e. the use of decision systems to be used by the
patients to self-prescribe Warfarin. This research presents the same weakness
we highlighted for the previous one: it provides devices that are supposed to
be used at home and that are not usable while on a trip. Another interesting
research developed in Denmark in 2011 [9], tested a telemedicine system to
be used on Personal Computers connected to the Internet. They involved 123
patients and proved, like the other researches presented above, the validity of
the adoption of telemedicine for anticoagulant therapy.
By analyzing the existing literature and the outcomes of our research work
we can state that there are two main advantages in implementing mHealth
solutions for chronic diseases: the first is more related to its social impact and is
the increase of patients’ awareness in their health condition. The second one is
related to a reduction of costs for the National Health Systems. As a significant
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Fig. 1 INR test result shows how long it takes for the blood of the patient to clot. The
more the INR value decreases to 1, the more thrombotic risks are present in the patient. On
the contrary, the more the INR value increases to 6, the more hemorrhagic risks exist.
example, Javitt et al [23] shows that the adoption of mHealth technology for
diabetes monitoring can lead to a significant reduction in medical expenditure,
estimated in about $3,000 per person per year.
3.2 INR Self-Monitoring and Self-Testing
INR self-testing devices are freely sold but not currently integrated into the
common practice for managing anticoagulant therapy adopted by the clinics.
INR self-testing devices allow to easily check the INR value with a finger stick
test. Using a lancet, a drop of blood is placed on a test strip that is then
inserted in the device.
The devices use three main methods to detect the INR value:
1. Monitoring of change in impedance of the sample when clotting occurs
2. Mechanical endpoint clotting mechanism, monitored optically
3. Mechanical clot detection. With all the devices, the result is available
within minutes
INR devices can be used in two ways:
1. Self-testing: the result has to be communicated to a healthcare practitioner
who is in charge of deciding the prescription of Warfarin and the date of
the next INR check;
2. Self-monitoring: the patients, after a proper and adequate training, self-
check their INR value and adjust their own Warfarin dosage.
Both these approaches has been widely studied in literature and medical
practice.
Many researches published in literature support self-testing and self-monitoring
as alternatives to the traditional standard care of patients of all ages [22], [33],
[38], and [29].
Two studies are specifically focused on one of the most diffused INR self-
testing devices ([21], [7]). The result of both papers support the fact that self-
management of oral anticoagulation therapy is feasible for selected patients
and could represent a significant improvement for the management of the
patients. Both researches point out that the devices used (CoaguCheck XS)
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appears to be sufficiently accurate and reliable and offers a good consistency
and stability as compared with traditional laboratory testing.
Several applications or prototypes have been designed recently to test
the feasibility of a mHealth approach to anticoagulation therapy. In 2018,
Smaradottir et al. [37] presented and evaluated a mobile application called
Warfarine Guide. The application, developed with a user-centred design ap-
proach, is a computer-assisted decision-support system aimed at helping pa-
tients in their management of anticoagulation therapy on the basis of the INR
values. The results of the evaluation show that the application effectively sup-
ported self-management of the anticoagulation therapy and that it helped the
patients by providing flexibility and decision support. Another prototype has
been designed in 2017 by a group of master students [18] with direct involve-
ment of the patients and provided interesting insights on how to design such
type of mhealth applications.
Also acceptability of mHealth and self-testing and self-monitoring has been
studied. A research of 2008 [39] evaluated an in-hospital education program
aimed at teaching INR self-testing to patients. The results of the study show
that the patients will continue to use the method without the need for in-
terval instruction. The research reported in [Tompsone438], proved how self-
monitoring of anticoagulation therapy is generally seen as a positive experience
by the patients. Especially interesting is the fact that from the interviews to
the participants it emerges how they became more conscious of their lifestyle
and started reflecting more on their INR level and on their routine without
becoming obsessed by it.
3.3 Open Problems and Challenges
From a sociotechnical perspective, by the results we obtained from the liter-
ature and state of the art review, we can point out that the problem with
the majority of the practical case studies in telemedicine and mHealth is that
the process of adoption of new technologies is in general very (and too) fast
and this mostly leads to the design of tools that do not fit the users need as
required and also do not fit into existing relationships between the stakehold-
ers and in the sociotechnical ecosystem in general. There is indeed very high
interest in the possibilities of managing chronic conditions at home by using
new IT solutions, especially the mobile ones, but the vast majority of trials
either fail or do not lead to the technology becoming embedded in normal
practice [14].
Said that, what we might need is a pre-trial sociotechnical analysis and
system development process in order to design tools that well fit both individ-
ual users and the broader setting in which they have to be adopted and put
at work.
As described before in this paper, we can classify the main challenges of
this research domain into four classes: quality of life, prescription management,
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treatment schedule, and nutrition. Here is a detailed list of the open problem
and challenges we obtained as results of our research:
1. Problems in the management of INR test schedule. In particular, the test
have to be done in certified facilities that could be far away from patients
home and that in any case imply time and resources allocation.
2. The communication of INR test results and of the related dosage is done
in different ways that often may not be accessible for children and elderly
and very time/resources consuming for pupils and working adults.
3. Difficulties in the management of the daily dosage of oral anticoagulants.
Patients have to keep a diary and to remember which dosage they have
to take in specific days of the week. Errors in this particular task may be
fatal.
4. Nutrition rules should be followed by the patient and very often they rep-
resent a limit to their social life. In fact, in case of doubts the patients do
not know how to decide if a certain food can be assumed or not and if such
food would affect the INR value.
5. The limitations given by coagulation diseases cause problems in social and
personal life, and may lead the patients to feel uncomfortable with their
daily life and sometimes isolated from the community.
The implementation of feasible, effective and safe mHealth systems can
represent a solution for these problems, thanks also to the growing diffusion
of smartphones and other mobile devices, and not only among young people.
Moreover, providing tools for PHR management may represent a powerful way
to empower patients and make them more aware of their health conditions and
less dependent from healthcare practitioners frequent personal contact. At the
same time the existence of digital PHRs enables the healthcare practitioners
to supervise their patients in a more organized way, avoiding charging the
National Health Systems, and the whole community, with excessive and un-
necessary costs. In the rest of this paper, we present the MANTRA (Mobile
ANticoagulant TheRApy) project and discuss its results. With MANTRA,
we were able to prove the concept of mHealth adoption in remote oral an-
ticoagulant therapy with an evaluation performed involving both healthcare
practitioners and patients.
4 Methodology
MANTRA was a research project in mHealth domain aimed at using mobile
technology to improve the quality of life of patients with coagulation diseases,
to save patients and healthcare workers time and resources, and to facilitate
the monitoring of anticoagulant therapy. The project was funded by the Lev-
erhulme Trust and the University of West London, as a proof of concept.
MANTRA proposed to provide the patient with an INR self-testing device
and a mobile device (an iPod) to transmit the INR results to the healthcare
practitioners. The GP or other healthcare practitioner is then able to review
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the results and transmit back to the patients the correct dose of anticoagulant
that they need to take and the date when they need to repeat the INR test.
The goal was to provide patients with a monitoring device to be used at home
to reduce the frequency of visits at the hospitals or clinics.
The project focused on (a) the feasibility of using this approach in the UK,
and on (b) patients and healthcare practitioners acceptability of the use of a
mHealth tool.
To investigate the feasibility of implementing MANTRA project in the
UK, GPs and other healthcare practitioners of the Argyle Surgery in Ealing,
London, were involved. Initially they were interviewed about their current
processes for managing patients on anticoagulation therapy, the demographics
of their patients receiving anticoagulation therapy, what factors would need
to be considered in order to implement the digital solution and their views
on its potential value. They have then participated in two further face-to-face
meetings to evaluate and test the prototypes designed and developed during
the project.
To study patients’ acceptability of the system, patients receiving antico-
agulant therapy who volunteer to participate were recruited from the Argyle
Surgery. They were interviewed about their views and expectations of an inter-
active system for managing their therapy. In particular, patients’ requirements
for the user interface were explored and incorporated into the design process.
They then have been asked to test the usability of the prototype’s user inter-
face. The research was mostly qualitative, with no collection of blood samples
or actual performance of INR tests.
With the MANTRA Project, the aim was to explore within the sociotech-
nical context of the NHS and a GP surgery, the validity of providing patients
with self-testing device to be used at home to reduce the frequency of visits
at the hospitals or clinics. Using these devices, the patients would be able to
send their INR test results to their GP and healthcare practitioners and to
receive back their prescriptions details.
Our research background is framed in a sociotechnical design domain,
which means evaluating technical and interface design decisions in terms of
the social context of use and associated practices and values [6]. This means
to not only understanding context and culture separately, but also involving
the identification and interpretation of pertinent cultural traits of the actors
and the context itself. The understanding and interpretation of the relation-
ship between context, culture and technology is thus well documented. The
sociotechnical approach is at the basis of the MANTRA Project, in that the
technical solutions we designed and tested consider not only the requirements
in terms of data management, data exchange and remote communication, but
also the end users’ and domain experts’ profiles, needs, skills and expectations
in order to support information and knowledge exchange and the construc-
tion of virtual communities aimed at collaborating for patients’ own good
[20]. Technical and social were considered as interconnected entities and the
co-evolution phenomenon [25] [5] [26] was taken into account when the pro-
totypes were designed and developed. Figure 2 shows the ecosystem of the
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MANTRA Project. The patient plays a central role and has to balance the
interactions among two separate but in many ways interconnected spheres of
existence: personal life and medical condition. From personal life side, fam-
ily and friends, caretakers, and coworkers represent the communities in which
the patients live and share with their members most of their time. On the
other side, their medical condition bounds them to specific activities and gives
them constraints on how they can live their life. GPs, nurses, and Healtcare
Assistants (HCAs) are the professionals who represent the patients references
for managing their condition. Given the variety of the potential patients, it
is important to study the context in the widest way possible, especially be-
cause the introduction of new technologies in the life of people affected by
chronic diseases presents many challenges. It is argued that technology accep-
tance and adoption depend to a great extent on how end users perceive the
technology [27]. It is only logical, therefore, that an understanding of users’
cognitive frames helps increasing acceptance and adoption of the technology.
Abdelnour-Nocera et al [1] also investigated how the usefulness of an Informa-
tion System (IS) can be deeply influenced by socio-cultural factors. They found
that users and designers may have different perceptions of usefulness and con-
sequently different expectations of a system. Then for a successful ICT design
in a context for which the technologies were not initially developed, designers
need to assess how the interpretive frames and practices of users in their local
context can shape the usefulness of existing or proposed systems. Ehn [15]
said once: “One of the oldest and widely accepted principles in the design of
computer-based tools for users is the principle know the user.” In the same
manner, the contextual inquiry, is an approach that consists of finding out
about the end users’ context and culture with their participation. It uses a
mixture of ethnography and other field research approaches providing design-
ers with “(...) grounded and detailed knowledge of user work as a basis for
their design.” [13]. The advantage with this approach is that users sometimes
reveal important issues and concerns that researchers may find worth explor-
ing and sometimes might not be elicited. Also, the focus should encompass
the whole design project (global team interests) [24], rather than just focus-
ing on a particular stage. Contextual inquiries as an approach are applied in
many forms using a variety of mixed methods. In addition to the most com-
mon methods used (survey questionnaires, interviews, focus groups), there are
also other User Centred Design (UCD)-oriented methodologies in use in this
approach that generate more details about the users’ mental models, cognitive
frame, initial and general perception of technologies envisaged. However, for
the purpose of this project, a more traditional approach was adopted using
unstructured interviews and questionnaires.
The general methodology of design research followed in the project is the
one described in Figure 3.
The outcome of the first phase was the definition the problem in context
that we built also through the literature review on telemedicine and on an-
ticoagulant therapy management that we presented earlier in this paper and
through the performance of some informal interviews to healthcare profession-
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Fig. 2 The sociotechnical ecosystem of MANTRA.
als to better understand how to operate in various scenarios. We then defined
future sociotechnical system scenarios and defined a set of personas [34][28]
that we used for examine technical options, i.e. the state of the art of exist-
ing mobile applications for self-monitoring of INR tests (designed for patients
living in urban context and not supporting the communication with doctors)
[3]. We then created paper prototypes of the two applications and evaluated
them with the doctors to validate the scenario and user requirements. During
the last phase we implemented two high-fidelity prototypes able to satisfy the
requirements and needs identified during the previous two phases.
It is important to point out that the MANTRA project was mainly about
the creation of a sociotechnical system and not just about the delivering of
a new mobile technology. Therefore, the aims of this research are more wide
than just prototyping, development and evaluation phases.
4.1 Ethics
We asked and obtained for Ethics approval from the College of Nursing, Mid-
wifery and Healthcare Research Scrutiny & Ethics Sub-committee of the Uni-
versity of West London and then we obtained the NRES Ethics approval fol-
lowing a Proportionate Review process. The specific kind of process, a sim-
plified one if compared with other Ethics approval processes of NHS is due to
the fact that the MANTRA Project did not consider the collection of blood
sample or the use of the self-testing devices. The evaluation of the Project was
mainly focused on the sociotechnical design of the idea as a proof of concept
and involved the patients and health practitioners only for testing the sce-
nario, interfaces and the idea at the base of the Project. Unfortunately, even
if the Proportionate Review process is by definition supposed to be simplified,
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Fig. 3 The adopted research methodology.
it was very time expensive and this affected severely the already limited time
resources for the Project, that lasted one year.
5 Results
5.1 Future Sociotechnical System Scenario
The scenario of use of the MANTRA applications was designed after the anal-
ysis of the results of the literature review and interviews performed to the
Argyle Surgery healthcare practitioners about their patients and their clinical
routine.
It sees the patient being provided with a INR self-testing device and a
mobile devices and application. Using these devices, the patient is able to
send her/his INR test results to her/his healthcare practitioner and to receive
back her/his prescriptions details. In this way, the patient will not have to visit
the GP every time the test is scheduled and will be able to travel and conduct
a freer life. Moreover, the patient can consult her/his clinical history with the
PHR functionality and to access a list of foods that help her/him in deciding
what to eat and to make sure Vitamin K is low enough to not influence the
INR results.
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5.2 Personas
On the basis of the interviews and on the study of literature review, we de-
signed two different Personas that are representative of the typical patients of
an anticoagulant clinic.
The first persona is Emma. “She is 52 years old and works as accountant
in her husband’s lawyer firm. Emma knows very well how to use a computer.
She feels able to learn something new when it is just explained to her. If she
needs IT help, she just searches the solution online. Because of her job, she
regularly uses the Internet and iPad and iPhone. Emma uses her smartphone
to make phone calls, to browse the web, to play games and uses many apps
that she installed personally. Emma loves to travel but unfortunately she has
been diagnosed with Pulmonary Thromboembolic Disease, and because of her
condition, she has to make frequent visits to her GP to measure the INR
values, so her trips cannot be as long as she desires. Emma dreams about a
future where she no longer has to go to the healthcare practitioner so often
and where she can spend more time traveling and living a more relaxed life.”
The second persona is Rupert. “He retired a year ago at the age of 64,
after working for 30 years as train operator. Rupert is extremely active. He
likes to go bowling once a week and loves his dancing classes. He is proud of
his old car and spends an hour or two each day maintaining it in his garage.
Rupert has being diagnosed with Proximal Atrial Fibrillation and since more
than one year ago he has to take Warfarin to manage his condition. His family
is checking on him and forced him to carry an Android smartphone with him
all the time. He only knows how to make calls and send SMS but does not use
applications. Rupert’s vision has gotten progressively worse over the past two
years and he wears glasses most of the time. He uses the computer at home
and accesses the Internet to email his older daughter who lives abroad. But
when he cannot read because of the text size, he just gets frustrated and gives
up. He desires to decrease healthcare practitioner visits and to spend his time
fixing his old car.”
These two personas constitute an illustrative exercise to show what is
needed for the further development of the project. We chose to present here
some key issues in the range of patients to explore the implications that they
may have on the design of mobile apps, but we also derived other personas for
the other stakeholders involved (e.g. GPs, nurses) that we omit in this paper.
5.3 Examination of Technical Options
5.3.1 Self Testing Devices
We analysed the state of the art of the INR self-testing devices available on
the market and selected the three most diffused ones, which are also the most
recommended ones by Health Institutions around the world and the main
information we gathered are reported in Table 1.
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Table 1 Comparison of three INR self-testing devices available on the market (updated on
June 2019)
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All these devices can be connected with PCs but their data can be collected
only through proprietary applications that up to now do not allow direct
access to the data for using other applications. Therefore, in the MANTRA
project and especially in the design of the scenario of use and the prototypes,
we considered a scenario where the patient is asked to input manually the
INR value in the application without being able to directly connect the INR
device to the mobile device. Of course, this does not represent the optimal
solution because of the high risk of errors that can be committed by the users.
However, testing the usability of a version of the application that presents such
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a challenging interaction modality assures us that in case of a further version
with an automatic loading of the INR value, the process could only be easier.
MANTRA Project is focused on self-testing approach, in that the aim is
not to replace the fundamental role of the healthcare practitioners in the anti-
coagulant therapy management, but to enable a remote communication among
healthcare practitioners and patients. Several studies (e.g., [36][4][10][12][16][40])
report that the INR self-testing devices are reliable instruments and suitable
alternative to conventional laboratory testing and that the INR results are
typically very well reproducible and well correlated.
In addition to the above, the MANTRA Project is not focused on self-
management but on self-testing, because the proposed system involves actively
the healthcare practitioners and is aimed at supporting the remote patient-
healthcare practitioner communication. This would help the healthcare prac-
titioners to supervise the patient health conditions avoiding the patient to be
left alone during his therapy.
5.3.2 Mobile Apps for Oral Anticoagulation Management
INR tracking mobile applications are available both for iOS (on iTunes) and
for Android (on Google Play) mobile devices. We analysed two applications
for iOS, INR & OAT Manager 4 and INR Pro 5, and two for Android, INR
Tracker 6 and INR Tracker (Warfarin Log) 7.
None of them are designed to support doctor-patient communication and
are not suitable for doctors. Some applications are available for free, while
others may cost up to £5. The two iOS applications allow keeping track of INR
results and Warfarin prescriptions. Both give the user the possibility to see
the INR results history represented on charts. The two Android applications
permit to track the INR results and Warfarin prescriptions, but only INR
Tracker offers the chart feature, while INR Tracker (Warfarin Log) allows to
send an email with the INR result to addresses of user’s choice but does not
support bidirectional communication or track of emails sent.
We applied heuristic evaluation method [32] to test the usability of the
four mobile applications listed above. Two usability experts were involved in
the evaluations.
For the evaluations we applied the 10 Nielsen’s heuristics: Visibility of
system status, match between system and real world, user control and freedom,
consistency and standards, error prevention, recognition rather than recall,
flexibility and efficiency of use, aesthetic and minimalist design, help users
recognize, diagnose, and recover from errors, help and documentation.
We adopted Nielsen’s severity ranking [31] to classify the usability issues:
1) Cosmetic problem only, 2) Minor usability problem, 3) Major usability
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Heuristic evaluation is a so-called discount usability method that is espe-
cially useful in early stage of design. It is cheap and fast and does not require
the participation of real end users. We evaluated the applications using these
tasks: 1) The user accesses the application. 2) The user saves the INR result.
3) The user browses the INR results history. 4) The user saves the Warfarin
prescription.
These four tasks represent the most important features required by an INR
tracker application and are all implemented in the four mobile applications
under analysis. Each of the two evaluators analysed each application twice
using the two Personas described previously in this paper (Emma and Rupert).
The application with the highest number of problems (34) is INR & OAT
Manager. The severity of the problems found by Rupert’s persona is so high
that he may not even be able to perform the basic tasks requested. In particu-
lar, the registration of INR results and prescriptions are the two most affected
tasks. For the other three applications, the evaluators have found more prob-
lems with Emma’s persona. Emma represents the archetypal expert user of
smartphones and mobile applications. Her familiarity with mobile interaction
makes her keener to find errors and deficiencies in an application. Moreover,
a user like Emma does not usually limit her exploration of an application to
the main tasks but happens to be more interested in interacting with the ap-
plication as a whole. On the other hand, Rupert being a novice in smartphone
use is more oriented to keep the use of applications at minimum, because of
his fear of the unknown.
Many issues may be resolved during use in time. In these cases, learnability
dimension is respected and supports the user to become more aware of the
applications potentials. However, the other usability issues deeply affect other
usability dimensions, like effectiveness, use satisfaction and most of all, safety.
Being the use of such applications related to health it is of great importance
that safety, efficiency and effectiveness are respected. To better understand the
kind of problems that affect the four mobile applications, we analysed them in
respect with the 10 Nielsen principles. The four principles that appear to fail
more are: Match between system and the real world, User control and freedom,
Consistency and standards, and Error prevention. The problems that most
seriously violate these four principles and that strongly affect effectiveness,
efficiency and safety use of the applications may be classified in three main
classes: Flexibility, readability, and data representation.
The applications show three serious issues in terms of flexibility that were
spotted by all the evaluations, both with Emma and Rupert personas: The
first issue regards the possibility of registering INR test results using a date
that is different from the current one. This may represent a limitation for the
patient that may be interested in registering results of tests taken in the previ-
ous days. Without this feature the patients are forced to register the INR test
results with wrong dates putting at risk their own safety. A second problem
is the unit used to specify the dosage of Warfarin that the doctor prescribes.
One of the applications asks the patient to set a default unit measure (mgs of
Warfarin contained in a tablet). After this setting operation, all the prescrip-
18 Barricelli et al.
tion registrations done with the application are expressed in term of units (e.g.
tablets) and no more in mgs. This may represent a serious problem because
of the different format of Warfarin tablets sold around the world. In the UK
and several other countries, Warfarin tablets are distributed in different blister
packages, each one having different mgs of Warfarin, with tablets of different
colours (one colour for each Warfarin dosage).
This implies that the patients may need to take each day tablets of different
kind (colour/dosage) and therefore a default unit is not suitable for them.
Besides, in other European countries, Warfarin is distributed in tablets that
may be cut into parts to obtain different dosages of the medicine. Also in this
case, the default unit is not the correct solution for the patients. The last
issue of this class of problems regards the interval of prescription: most of the
applications do not allow the patients to freely specify the initial and final date
of the prescription received by their GP. Typically, the applications offer the
possibility to register a daily prescription (registered day by day) or a weekly
prescription (from Monday to Sunday, with no possibility of personalizing this
format).
As to the readability class of problem, the evaluations made with Rupert’s
persona pointed out the great importance of using fonts, colours (for text and
background) and icons that may be easily read by patients. One important
option could be to implement a feature for resizing the text size to support
the accessibility especially for elderly and/or patients with sight problems.
The issues related to the data representation class regard the possibility of
browsing the INR test results history of the patient. It is of fundamental
importance for the patients to be able to access the previous tests results to
be more aware of their health conditions. To this aim, it is of great importance
to offer a feature for INR test results representation in charts and lists. Some
applications already offer such charts and lists, but they are not enough flexible
and interactive. For example, it is not possible to specify a range of dates to use
for the data visualization and the charts/lists are not interactive, i.e. the values
visualized are not clickable and is not possible to see more information about
the INR values and relative prescriptions. Despite the limits of the heuristic
evaluation method, this preliminary analysis allowed us to understand the
potentials of the use of mobile devices in this context.
5.4 Paper Prototypes
We developed two vertical paper prototypes: a paper prototype for patients
and one for healthcare practitioners. Paperboard prototyping is a very popular
approach to low-fidelity prototyping and is used especially for developing an
early understanding of an interface requirements, look and feel, and layout.
Paper prototypes are low-cost solutions and enable the designers to engage the
domain experts and/or the end users in an early-stage evaluation of the ongo-
ing design project. To evaluate the paper prototypes we recorded interaction
videos, and we showed them to healthcare practitioners posing questions and
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collecting comments and suggestions. The feedbacks we collected were used to
improve the design of the prototypes that were then translated into interac-
tive high-fidelity prototypes as described later in the paper. It is important
to state that we designed our prototypes considering to provide the patients
with iPods, that are small and easy to use and bring along everyday, while we
considered iPads for the general practitioners, who are more often required to
visualize larger amount of data at the same time and may use the device for
taking extensive notes on particular patients conditions. A few views of the
paper prototypes are given in Figure 4.
5.5 High-Fidelity Interactive Prototypes Design and Development
Following the evaluation of the paper prototypes, we started the design and
development of the two interactive high-fidelity prototypes for the MANTRA
Project. With the design of the apps we tried to assess the problems detected
in the study of the state of the art of existing apps for oral anticoagulation
therapy monitoring, especially with what concerns readability. In fact, we pro-
vide access to previous tests results visually represented in different ways, both
as lists or charts, trying to face the problems that may derive both from elderly
problems in reading and from the interaction with touchscreen devices, often
small.
We developed the apps for iOS 5.0+ operating system in Objective-C lan-
guage using XCode IDE v4.6 and including the CorePlot plotting framework.
Views of the MANTRA app for the patients are given in Figure 5. In the
top row of the picture, respectively the views of the home page, the INR results
input and the results sending are shown. In the bottom row, the first view is
the one that shows the INR results chart and allows the patients to access their
PHR. The second view is the list of food for vitamin K assumption guiding
and the last view is the prescription received by the healthcare practitioner.
Views of the healthcare practitioners’ MANTRA app are shown in Figure
6. In the top row of the picture, respectively the screenshots of the home page,
the list of patients and one patient’s record with just received INR results are
shown. In the bottom row, the first view is the one that shows the INR results
chart for a specific patient and allows the healthcare practitioner to access
their records. The second screenshot shows the first step of a prescription
creation that allows the user to choose INR period (initial and final date) and
the date for the next check. The last view shows the second step of creation of
the prescription where the actual dosages of Warfarin is selected by the user.
6 Evaluation of the Sociotechnical Scenario
The evaluation of the high-fidelity prototypes was performed at the Argyle
Surgery in two distinct phases. The first was focused on studying the usability
of the prototype for the GPs and other healthcare practitioners. The second
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Fig. 4 In the top row, three views of the patients’ app are shown, respectively: the home
view, the view for sending the INR results, and the list of food for vitamin K assumption
supervision. In the bottom row, two views of the healthcare practitioners app are show, and
are: the patients list and a patient record and status information.
phase was aimed at evaluating the usability of the prototype designed for
the patients by involving patients of the surgery who were on anticoagulant
therapy.
6.1 Evaluation with the GPs and other Healthcare Practitioners
We were able to involve 5 healthcare practitioners in two separate occasions:
a first time for individual meetings and a second one for a focus group.
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Fig. 5 Some views of the MANTRA app for the patients.
6.1.1 Individual meetings
During the individual meetings, we started with a semi-structured interview
asking the participants about their current process in managing patients on
anticoagulation therapy, the demographics of their patients receiving antico-
agulation prescriptions, what factors would need to be considered in order to
implement the digital solution and their views on its potential value. We also
asked them about their experience in the health domain and the number of
patients they manage.
We interviewed two GPs, one nurse and two Healthcare Assistants (HCAs).
The nurse had 30 years’ experience in the health domain, the HCAs 20 years
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Fig. 6 Some views of the MANTRA app for the healthcare practitioners. This version is
the final one, obtained after the performance of the evaluation described in the next section.
and 1 year and half, respectively, while the healthcare practitioners have 9 and
15 years of experience. The nurse and the HCAs were the ones in charge of
performing the INR tests and insert the results in the INR Star system, an
interactive system that automatically computes the dosage of Warfarin to be
prescribed to a patient. If the INR result is too high or too low (extremely
out of the range), the nurse and HCAs have to consult with a GP. The three
participants managed 94 persons who were patients of the surgery, patients of
other surgeries or nursing homes residents. The average age was about 60, the
youngest patient was 37 and the oldest was in his 90s. Some of them were on
a life-long anticoagulant therapy while others were only recovering from some
temporary diseases.
The two GPs were the ones responsible for the management of the antico-
agulant clinic, both for the patients of the surgery and for the ones of other
surgeries and nursing homes. They supervised the nurse and HCAs activity
and intervene in case an urgent prescription is needed.
The most important outcomes we had from the interviews regard the fea-
tures that a mobile application for anticoagulant therapy should have and
the sociotechnical factors to be considered in changing the current process of
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the anticoagulant clinic. As to the application’s features, the most recurrent
responses were: simple to use, efficient, user-friendly, simple, safe, and reliable.
The important sociotechnical factors to be considered that the partici-
pants named were: a) the application should lead to time savings given the
constrained nature of resources in the NHS, b) should support healthcare prac-
titioners mobility especially when visiting nursing homes, since to engage in
this type of activity requires time and resources that are often hard to allo-
cate and expensive, c) automatic suggestion of prescription should be avoided,
because the role of the healthcare practitioner should remain central in the an-
ticoagulant therapy, and d) patients have to feel responsible for what they are
doing in order to rise awareness of risks and benefits related with anticoagulant
therapy.
6.1.2 Usability evaluations
At the end of the interview, we involved the healthcare professionals in in-
dividual usability test during which we asked them to perform a task-based
evaluation of a first version of the high-fidelity prototype we created.
The tests lasted between 20 and 30 minutes average and pointed out from
4 to 6 problems each. The participants had all previous experience in using
mobile devices such tablets and smartphones and the operating systems known
to them were iOS, Android, and Blackberry. They had no difficulties in using
the application and performed all the tasks requested in the test. The results
pointed out some usability problems to be fixed but the overall satisfaction of
the use of the prototype was high.
The main problems regarded the visibility of notification icons (when a
patient sends an INR test results a notification icon appears on the list of
patients) that needed to be larger and the prescription creation procedure
that was not completely in line with the actual practice in the UK system.
Another change that was applied passing from the first to the second ver-
sion of the high-fidelity prototypes after the interviews with Argyle Surgery
team, was on the Vitamin K section of the application: we adopted a colour-
code scale for suggesting what food the patient has to avoid, limit and can
freely eat. During the interviews, we were asked to pair some textual descrip-
tion with the colours and the result is the one presented in the pictures in the
previous section of this report: we added OK, NO, and MODERATION to
the colours to make the message more clear to the user.
The last change that was requested by xxx and was implemented in the
final version of the high-fidelity prototype was to ask the patient to specify
what other medication they took before taking the INR test. This would help
the healthcare practitioners to understand the possible influence factors on the
anticoagulation disease of the patient and in formulating a good prescription
for the next period of time.
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6.1.3 Focus group
After the individual usability test we applied the requested changes and im-
provements to the prototype, and we met the participants in a final focus group
during which the new final version of the application was shown and discussed.
All the problems pointed out during the individual meetings were fixed and
no other requests were made. The participants discussed the potentials of the
introduction of the application and the new approach to anticoagulant therapy
and proposed a new scenario of use that would involve the GPs at the Surgery
and the nurses at the nursing homes: currently, healthcare practitioners have
to personally visit nursing homes to collect INR results. In the new scenario,
the nursing homes’ nurses and HCAs will perform the INR tests and send via
a MANTRA app the results to the surgery, where they will be evaluated by
the healthcare practitioners who will then send back to the nursing homes
the proper prescriptions of warfarin. The remote communication among the
two sites would avoid the HCAs and nurses of the Surgery to visit personally
the nursing homes to collect the INR test results and would make the process
easier and faster.
6.2 Evaluation with the Patients
We were able to involve 6 patients at the Argyle Surgery for individual meet-
ings (see 2). During the meetings we perform a semi-structured interview with
each them, and we also involved them in a usability test of the MANTRA ap-
plication. For the usability test the final version of the high-fidelity prototype
was used.
All the patients had to take the INR test every 2/3 weeks or 1 month. 4 out
of six patients were retired while the other two still worked, but they both did
not have any problems in visiting the Surgery because they lived and worked
in the neighborhood. All the patients would positively consider the possibility
of having an INR self-testing device at home and to communicate with the
healthcare practitioners on a distance because they felt it would be easier
and faster. Even if some of the patients had only a little or no experience at
all in using smartphones and touchscreen interaction, they seemed to have no
difficulties at all in interacting with the application and successfully performed
all the tasks in the list. The three patients who never used a touchscreen before
received an initial explanation about how to tap on a graphic element on the
interface, how to scroll a page and how to use the wheel widget.
The patients did not suggest specific changes to the application and demon-
strate to understand the entire process of sending the INR test result and
receiving the prescription from the healthcare practitioner. One of the two
patients strongly appreciated the Vitamin K list because he said he was used
to reading one that was printed on paper but the digital one was easier to be
used. Two of the patients did not find useful the Alarm feature and said that
they are used to taking their medicine every day at the same time without
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needing an alarm however, they liked to have the chance to see the prescription
details on the phone. All the patients also described the application as useful
and easy to use.
6.3 Limitations of the Study
The present research has some limitations, especially related to the number of
participants involved in the study, even if all the involved patients and health-
care professionals were expert of the problem at hand and of the challenges
and open problems to be addressed. To overcome these limitations, a further
study with more patients and domain experts should be developed and even-
tually the personas created for this study would be updated accordingly to
the new outcomes.
7 Discussion and Conclusion
To understand what has the proof of concept study of the MANTRA project
found we can start reflecting on the effects of technology on the conversation
between patient and GP. This peculiar aspect of the synchronous co-located
interaction between the two actors may often lead to a loss of empathy in
the way the GP addresses the patient’s needs. This emerges clearly from the
literature review and the interviews with the domain experts. The need of
learning new ways of communication (asynchronous remote interaction, that
are mainly related to the risk of patients and providers being afraid of learning
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new ways of communicating with each other and help them understanding the
potentials of this specific setting.)
The changes in the traditional roles of patients and healthcare providers
(i.e., the changes in the traditional roles of patients and healthcare providers
with the introduction of more and more pervasive and ubiquitous technologies)
and the proactivity of patients in sending their own test results to the GPs
may lead to great advantages in a long term perspective, but it is undoubtedly
hard to be understood and acknowledged in the short term.
With reference to the literature on eHealth, MANTRA outcomes positively
respond to the critical issues described in Section 3. Specifically, as to the five
potential changes, highlighted in [11], that can be caused by the introduction
of remote and mobile health:
1. “Internet health Websites may become a replacement for face-to-face con-
sultations influencing deeply the patients understanding of their health
conditions and putting at risk their own safety and future.” The MANTRA
approach is aimed at establishing a remote form of communication between
patient and healthcare practitioners and not on the replacement of the con-
sultations with an automatic system for self-management. In fact, in our
study we developed and tested systems for the self-testing of INR and not
for self-management of anticoagulant therapy. This was positively evalu-
ated by the healtcare practitioners involved in the individual meetings,
usability testing and focus group and also by the patients involved in the
user tests.
2. “Supplement existing relationships and forms of care, that means making
the computer-mediated conversation between patient and GP an actual
bi-directional transaction but always allowing the receiver (the GP) driv-
ing the communication.” The relationship between patient and healthcare
practitioners remains bi-directional. During the focus group, one GP ex-
pressed a great interest in the integration of a new feature in the system:
the possibility of sending the patient some messages asking her/him to visit
the clinic for further examination.
3. “Create favorable circumstances for improvements or for strengthening pa-
tient participation, by mitigating mechanism, offering a training ground,
and implementing a so-called lever effect”. Both patients and healthcare
practitioners expressed their interest in using the MANTRA approach for
improving the quality of life of the people under anticoagulant medications.
Patient participation is one of the main and direct consequences of the ap-
plication of such approach and as a HCA suggested, especially the younger
patients would probably be interested in changing their current therapy
management situation.
4. “Managing the issues that the healthcare practitioners might encounter,
like the feeling of power loss, the fear of damaging the relationship with the
patients during a remote conversation, and to lose control over the sources
of information that tend to proliferate very fast due to technological ad-
vances.” We developed usable prototypes that demonstrated to patients
Sociotechnical Design for Mobile Anticoagulant Therapy 27
and healthcare practitioners that the management of remote communica-
tion of anticoagulant prescriptions can be easy and secure. The possibility
of checking on the history of patients gives the GPs and HCAs a control
over information and the use of mobile devices makes them feel free to
manage the clinic in a more flexible way.
5. “Forcing the patient to become a more capable conversation partner be-
cause s/he needs to provide the doctor with information that the doctor
cannot obtain through remote conversation.” Despite the simplicity of the
prototypes, they allow the healthcare practitioners to collect all the infor-
mation they need for submitting a prescription.
From the results of this study, we were able to address the sociotechnical
challenges we identified and classified into four main classes: quality of life,
prescription management, treatment schedule, and nutrition.
In particular, with our research and design we addressed the main open
problems/challenges we described in Section 3.3:
1. Problems in the management of INR test schedule. In particular, the test
have to be done in certified facilities that could be far away from pa-
tients home and that in any case imply time and resources allocation. With
MANTRA the patients are allowed to perform the INR tests independently
and to send the results to the clinic for receiving the right prescription in
a remote way. This approach gives the patient more freedom and less con-
strained by test schedules.
2. The communication of INR test results and of the related dosage is done
in different ways that often may not be accessible for children and elderly
and very time/resources consuming for pupils and working adults. Our
approach allows to manage a remote communication protocol that helps
not only the patients but also their families and/or caregivers in managing
the anticoaugulant therapy remotely and in a easier way.
3. Difficulties in the management of the daily dosage of oral anticoagulants.
Patients have to keep a diary and to remember which dosage they have to
take in specific days of the week. Errors in this particular task may be fatal.
The use of mobile devices in the MANTRA approach helps the patients in
remembering their pills thanks to alarms and calendar features.
4. Nutrition rules should be followed by the patient and very often they rep-
resent a limit to their social life. In fact, in case of doubts the patients do
not know how to decide if a certain food can be assumed or not and if such
food would affect the INR value.
5. The limitations given by coagulation diseases cause problems in social and
personal life, and may lead the patients to feel uncomfortable with their
daily life and sometimes isolated from the community.
The methodology and approach we applied in MANTRA Project can be
easily be adapted for other chronic diseases remote management cases. In par-
ticular, four sociotechnical factors can be derived from this experience and
applied to different therapy management contexts in public-funded health in-
stitutes:
28 Barricelli et al.
1. Flexibility: drugs prescription modalities is strictly linked to regulations of
the local National health systems. Internationalization of software allows to
adapt the interface to the user’s Country of residence, enabling the designer
and developers to create application that can be used in different places
but sharing the same aim.
2. Accessibility: most of the patients who follow an anticoagulant therapy
are elderly. Since with age come very often sight problems it is highly im-
portant to design accessible interfaces that cannot lead the user in making
mistakes. This applies both to software and to hardware: choosing the right
device and interaction techniques enhances the chances of success of the
introduction of digital solutions in chronic diseases remote management.
3. Data visualization: it is fundamental for the user to access history of ther-
apy to learn from previous behavior and to monitor improvement or retro-
gression. To show a large amount of data in an effective and efficient way
calls for an accurate design of interface and interaction style.
4. Safety: together with efficiency and effectiveness, safeness is one of the
most important characteristics that a mHealth application should have to
be considered as appropriate for a clinical use.
As a future development, we plan to expand the study to other Countries
and to focus on the development of the final mobile applications by improv-
ing the high-fidelity prototypes using the results we obtained from the us-
ability evaluations. We also would like to explore different application of the
MANTRA approach also following what suggested by the Argyle Surgery’s
healthcare practitioners about using mobile devices to remotely managing
nursing homes.
8 Ethical statement
The authors whose names are listed above certify that all procedures performed
in studies involving human participants were in accordance with the ethical
standards of the institutional and/or national research committee and with
the 1964 Helsinki declaration and its later amendments or comparable ethical
standards. The Project went under Ethical approval through the NHS and
University of West London in 2013.
9 Acknowledgements
Acknowledgements The MANTRA Project was funded by the Leverhulme Trust with a
Visiting Fellowship for Barbara Rita Barricelli at the University of West London.
References
1. Abdelnour-Nocera, J.: The Social Construct of Usefulness: An intercultural study of
producers and users of a business information system. VDM Verlag (2007)
Sociotechnical Design for Mobile Anticoagulant Therapy 29
2. Barricelli, B., Devis, Y.: Mhealth in resource-constrained environments. International
Journal of Sociotechnology and Knowledge Development 6(1), 18–35 (2014). DOI
10.4018/ijskd.2014010102
3. Barricelli, B.R., Devis, Y., Abdelnour-Nocera, J., Wilson, J., Moore, J.: Mantra: Mobile
anticoagulant therapy management. In: 2013 7th International Conference on Pervasive
Computing Technologies for Healthcare and Workshops, pp. 278–281. IEEE (2013).
DOI 10.4108/icst.pervasivehealth.2013.252096
4. Bussey, H.I., Chiquette, E., M., B.T., Lowder-Bender, K., Kraynak, M.A., Linn, W.D.,
Farnett, L., Clark, G.M.: A statistical and clinical evaluation of fingerstick and routine
laboratory prothrombin time measurements. Pharmacotherapy 17(5), 861–866 (1997).
DOI 10.1002/j.1875-9114.1997.tb03775.x
5. Callon, M.: Mapping the Dynamics of Science and Technology: Sociology of Science in
the Real World. Sheridan House (1986)
6. Camara, S., Abdelnour-Nocera, J.: Revealing the socio-technical context of design set-
tings: Toward participatory is design. International Journal of Human-Computer Inter-
action 29(4), 289–307 (2013). DOI 10.1080/10447318.2013.765767
7. Chen, Q.L., Dong, L., Dong, Y.J., Zhao, S.L., Fu, B., Wang, Y.Q., Jiang, H.:
Security and cost comparison of inr self-testing and conventional hospital inr
testing in patients with mechanical heart valve replacement. Journal of Car-
diothoracic Surgery 10(1) (2015). DOI 10.1186/s13019-015-0205-1. URL
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928669219&doi=10.
1186%2fs13019-015-0205-1&partnerID=40&md5=311e38829a90a399bca08955e6ee1250
8. Chen, Y., Cheng, K., Tang, C., Siek, K.A., Bardram, J.E.: Is my doctor listening to
me?: Impact of health it systems on patient-provider interaction. In: CHI ’13 Extended
Abstracts on Human Factors in Computing Systems, CHI EA ’13, pp. 2419–2426. ACM
(2013). DOI 10.1145/2468356.2468791
9. Christensen, H., Lauterlein, J., Sørensen, P., Petersen, E., Madsen, J., Brandslund,
I.: Home management of oral anticoagulation via telemedicine versus conventional
hospitalbased treatment. Telemedicine and eHealth 17(3), 169–176 (2011). DOI
10.1089/tmj.2010.0128
10. Cromheecke, M.E., Levi, M., Colly, L.P., de Mol, B.J.M., Prins, M.H., Hutten, B.A.,
Mak, R., Keyzers, K.C.J., Büller, H.R.: Oral anticoagulation self-management and man-
agement by a specialist anticoagulation clinic: a randomised cross-over comparison.
The Lancet 356(9224), 97–102 (2000). DOI http://dx.doi.org/10.1016/S0140-6736(00)
02470-3
11. Dedding, C., van Doorn, R., Winkler, L., Reis, R.: How will e-health affect patient
participation in the clinic? a review of e-health studies and the current evidence for
changes in the relationship between medical professionals and patients. Social Science
& Medicine 72, 49–53 (2011). DOI 10.1016/j.socscimed.2010.10.017
12. Dorfman, D.M., Goonan, E.M., Boutilier, M.K., Jarolim, P., Tanasijevica, M., Gold-
haber, S.Z.: Pointofcare (poc) versus central laboratory instrumentation for monitor-
ing oral anticoagulation. Vascular Medicine 10(1), 232–237 (2005). DOI 10.1191/
1358863x05vm587oa
13. Duncan, A.S., Beabes, M.A.: Contextual inquiry: grounding your design in user’s work.
Conference companion on Human factors in computing systems. ACM Press (1995)
14. Eason, K., Waterson, P., Davda, P.: The sociotechnical challenge of integrating tele-
health and telecare into health and social care for the elderly)., pp. 1177–1189. IGI
Global (2015)
15. Ehn, P.: Work-Oriented Design of Computer Artifacts. L. Erlbaum Associates Inc.
(1990)
16. Gardiner, C., Williams, K., Mackie, I.J., Machin, S.J., Cohen, H.: Patient selftesting
is a reliable and acceptable alternative to laboratory inr monitoring. Br J Haematol
128(2), 242–247 (2005). DOI 10.1111/j.1365-2141.2004.05300.x
17. Gardiner, C., Williams, K., Mackie, I.J., Machin, S.J., Cohen, H.: Can oral anticoagu-
lation be managed using telemedicine and patient self-testing? a pilot study. Clinical &
Laboratory Haematology 28(2), 122–125 (2006). DOI 10.1111/j.1365-2257.2006.00759.x
18. Gerdes, M., Martinez, S., Smaradottir, B., Fensli, R., Jortveit, J.: War-
farin guide: Co-design of a mobile computer-assisted anticoagulant therapy.
30 Barricelli et al.




19. Hamine, S., Gerth-Guyette, E., Faulx, D., Green, B.B., Ginsburg, S.A.: Impact of
mhealth chronic disease management on treatment adherence and patient outcomes:
A systematic review. J Med Internet Res 17(2), e52 (2015). DOI 10.2196/jmir.3951
20. Hansen, T.R.: Strings of experiments: looking at the design process as a set of socio-
technical experiments. In: Proc. PDC 2006, pp. 1–10. ACM (2006)
21. Hasenkam, J., Kimose, H.H., Knudsen, L., Grønnesby, H., Halborg, J., Christensen, T.,
Attermann, J., Pilegaard, H.: Self management of oral anticoagulant therapy after heart
valve replacement. European Journal of Cardio-Thoracic Surgery 11(5), 935–42 (1997).
DOI 10.1016/S1010-7940(97)01204-9
22. Heneghan, C., Ward, A., Perera, R.: Self-monitoring of oral anticoagulation: Systematic
review and meta-analysis of individual patient data. The Lancet 379(9813), 322–334
(2012). DOI 10.1016/S0140-6736(11)61294-4. URL https://www.scopus.com/inward/
record.uri?eid=2-s2.0-84856387132&doi=10.1016%2fS0140-6736%2811%2961294-4&
partnerID=40&md5=dd5085ca2d4e29219361fb81ae1af9f5
23. Javitt, J.C., Shane Reese, C., Derrick, M.K.: Deployment of an mhealth patient monitor-
ing solution for diabetes— improved glucose monitoring leads to reduction in medical ex-
penditure. US Endocrinology 9(2), 119–123 (2013). DOI 10.17925/USE.2013.09.02.119
24. Kleimann, S.: Response to ”using contextual inquiry”. SIGDOC Asterisk J. Comput.
Doc. 20(1), 22–24 (1996). DOI 10.1145/227614.228150
25. Latour, B.: We Have Never Been Modern. Harvard University Press (1993)
26. Law, J., Hassard, J.: Actor Network Theory and After. Blackwell (1999)
27. Lin, A., Silva, L.: The social and political construction of technological frames. Eur. J.
Inf. Syst. 14, 49–59 (2005)
28. Miaskiewicz, T., Kozar, K.: Personas and user-centered design: How can personas benefit
product design processes? Design Studies (32), 417–430 (2011). DOI 10.1016/j.destud.
2011.03.003
29. Nagler, M., Bachmann, L., Schmid, P., Raddatz Müller, P., Wuillemin, W.: Patient
self-management of oral anticoagulation with vitamin k antagonists in every-
day practice: Efficacy and safety in a nationwide long-term prospective cohort
study. PLoS ONE 9(4) (2014). DOI 10.1371/journal.pone.0095761. URL https:
//www.scopus.com/inward/record.uri?eid=2-s2.0-84899686376&doi=10.1371%
2fjournal.pone.0095761&partnerID=40&md5=4397a1ea04858664f836a3cb7a2fc9a9
30. NHS: National patient safety agency (npsa nhs) guide to setting up an anticoagulation
clinic in primary care. Tech. rep., NHS (2016). URL http://www.slcsn.nhs.uk/af/
af-anticoagulation.html
31. Nielsen, J., Mack, R.: Usability inspection methods. Wiley (1994)
32. Nielsen, J., Molich, R.: Heuristic evaluation of user interfaces. In: Proc. ACM CHI 1990
Conf., pp. 249–256 (1990)
33. Pozzi, M., Mitchell, J., Henaine, A., Hanna, N., Safi, O., Henaine, R.: International
normalized ratio self-testing and self-management: Improving patient outcomes. Vas-
cular Health and Risk Management 12, 387–392 (2016). DOI 10.2147/VHRM.S85031.
URL https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994453150&doi=
10.2147%2fVHRM.S85031&partnerID=40&md5=c00005415578e85451018fac5ec24382
34. Pruitt, J., Grudin, J.: Personas: practice and theory. In: Proceedings of the 2003 con-
ference on Designing for user experiences (DUX ’03), pp. 1–15 (2003)
35. Salvador, C.H., Ruiz-Sanchez, A., de Mingo, M.A.G., Carmona Rodriguez, M., Carrasco,
M.P., Sagredo, P.G., Fragua, J.A., Caballero-Martinez, F., Garcia-Lopez, F., Marquez-
Montes, J., Monteagudo, J.L.: Evaluation of a telemedicine-based service for the follow-
up and monitoring of patients treated with oral anticoagulant therapy. Trans. Info.
Tech. Biomed. 12(6), 696–706 (2008). DOI 10.1109/TITB.2008.910750
36. Schneeweiss, S., Gagne, J.J., Patrick, A.R., Choudhry, N.K., Avorn, J.: Compara-
tive efficacy and safety of new oral anticoagulants in patients with atrial fibrilla-
tion. Circulation: Cardiovascular Quality and Outcomes 5, 480–486 (2012). DOI
10.1161/CIRCOUTCOMES.112.965988
Sociotechnical Design for Mobile Anticoagulant Therapy 31
37. Smaradottir, B., Martinez, S., Borycki, E., Loudon, G., Kushniruk, A., Jortveit,
J., Fensli, R.: User evaluation of a smartphone application for anticoagulation




38. Thompson, J., Burkhart, H., Daly, R., Dearani, J., Joyce, L., Suri, R., Schaff,
H.: Anticoagulation early after mechanical valve replacement: Improved man-
agement with patient self-testing. Journal of Thoracic and Cardiovascular
Surgery 146(3), 599–604 (2013). DOI 10.1016/j.jtcvs.2012.03.088. URL https:
//www.scopus.com/inward/record.uri?eid=2-s2.0-84881616330&doi=10.1016%2fj.
jtcvs.2012.03.088&partnerID=40&md5=d497ed8655fad35a24d1d01a60c8d8a9
39. Thompson, J., Sundt, T., Sarano, M., Santrach, P., Schaff, H.: In-patient in-
ternational normalized ratio self-testing instruction after mechanical heart valve




40. Tripodi, A.: Prothrombin time international normalized ratio monitoring by selftesting.
Curr Opin Hematol 11(3), 141–145 (2004)
